Clearmind Medicine (CMND) Exchange Rate Effect (2022 - 2026)
Clearmind Medicine's (CMND) quarterly Exchange Rate Effect came in at -$1949.0 in Q2 2026, down 9845.0% on a YoY basis from $20.0 in Q2 2025, and down 178.68% quarter-over-quarter from $2477.0 in Q1 2026.
Powered by 
Analysis
Clearmind Medicine (CMND) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Clearmind Medicine (CMND) has reported Exchange Rate Effect for 5 consecutive years, with -$1949.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 9845.0% year-over-year to -$1949.0; the trailing twelve-month figure through Apr 2026 stood at $5181.0 (up 189.19% YoY), and the FY2025 full-year result was $3217.0, up 127.86% from the prior year.
- Exchange Rate Effect declined to -$1949.0 in Q2 2026 per CMND's latest filing, from $2477.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $5514.0 in Q3 2025 and bottomed at -$37708.0 in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$4042.4 across 5 years, with a median of -$861.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Exchange Rate Effect soared 750.0% in 2023, then plunged 9845.0% in 2026.
- Over 5 years, Exchange Rate Effect stood at -$23007.0 in 2022, then sank by 63.9% to -$37708.0 in 2023, then jumped by 96.04% to -$1495.0 in 2024, then soared by 42.41% to -$861.0 in 2025, then plunged by 126.36% to -$1949.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1949.0, $2477.0, and -$861.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.84 Bn | 626.09 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 449.07 Bn | 442.50 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 362.31 Bn | 355.17 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 268.33 Bn | 260.64 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 157.40 Bn | 145.70 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.36 Bn | 44.97 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 43.21 Bn | 43.21 Bn | - | - |
| 8 | Incyte | 25.31 Bn | 20.77 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Clearmind Medicine | 12,960.64 | -13.58 Mn | - | -1,949.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -1,949.00 |
| Jan 31, 2026 | 2,477.00 |
| Oct 31, 2025 | -861.00 |
| Jul 31, 2025 | 5,514.00 |
| Apr 30, 2025 | 20.00 |
| Jan 31, 2025 | -1,456.00 |
| Oct 31, 2024 | -1,495.00 |
| Jul 31, 2024 | -2,878.00 |
| Apr 30, 2024 | -10,898.00 |
| Jan 31, 2024 | 3,723.00 |
| Oct 31, 2023 | -37,708.00 |
| Jul 31, 2023 | 1,207.00 |
| Apr 30, 2023 | 2,991.00 |
| Jan 31, 2023 | -4,224.00 |
| Oct 31, 2022 | -23,007.00 |
| Jul 31, 2022 | 142.00 |
| Jan 31, 2022 | -319.19 |